Showing results (281-290 of 313) with videos related to
Sort By:
Pageof 32
Clinical Pharmacology and Therapeutics|November 2, 2020
Genetic Risk Factors in Drug-Induced Liver Injury Due to Isoniazid-Containing Antituberculosis Drug RegimensPaola Nicoletti, Harshad Devarbhavi, Ashish Goel, et al.Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|June 28, 2021
Plasma Von Willebrand Factor Levels Predict Survival in COVID-19 Patients Across the Entire Spectrum of Disease SeverityVineeth Varghese Thomas, Santhosh E Kumar, Vijay Alexander, et al.Journal of the American Medical Directors Association|February 24, 2015
An international definition for "nursing home"Angela M Sanford, Martin Orrell, Debbie Tolson, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 27, 2025
Long-term outcomes of transjugular intrahepatic portosystemic shunt in Budd-Chiari syndrome: A multicenter studyShekhar Swaroop, Asisha M Janeela, Arun Valsan, et al.Journal of Clinical and Experimental Hepatology|May 11, 2018
INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman StatementsAnil Arora, Shivaram P Singh, Ashish Kumar, et al.Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|December 10, 2021
Management of portal hypertensive upper gastrointestinal bleeding: Report of the Coorg Consensus workshop of the Indian Society of Gastroenterology Task Force on Upper Gastrointestinal BleedingShivaram P Singh, Manav Wadhawan, Subrat K Acharya, et al.Journal of the American Medical Directors Association|May 28, 2017
IAGG/IAGG GARN International Survey of End-of-Life Care in Nursing HomesCara L Wallace, Daniel Swagerty, Mario Barbagallo, et al.Journal of Clinical and Experimental Hepatology|December 21, 2018
INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosupressants, or CorticosteroidsAnil Arora, Anil C Anand, Ashish Kumar, et al.World Journal of Clinical Oncology|July 1, 2024
Characteristics and distinct prognostic determinants of individuals with hepatosplenic T-cell lymphoma over the past two decadesAyrton Bangolo, Pierre Fwelo, Shraboni Dey, et al.Liver International : Official Journal of the International Association for the Study of the Liver|July 7, 2022
APASL-ACLF Research Consortium-Artificial Intelligence (AARC-AI) model precisely predicts outcomes in acute-on-chronic liver failure patientsNipun Verma, Ashok Choudhury, Virendra Singh, et al.Pageof 32